Person with cancer—research trial type, code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Research trial type |
METEOR identifier: | 458194 |
Registration status: | Health, Standard 04/02/2015 |
Definition: | The type of research trial or study in which the person with cancer has been enrolled, as represented by a code. |
Data Element Concept: | Person with cancer—research trial type |
Value Domain: | Research trial type code N |
Collection and usage attributes | |
Guide for use: | CODE 1 Clinical trial A clinical trial is a controlled experiment involving a defined set of subjects and having a clinical event as an outcome measure. It is intended to yield scientifically valid information about the efficacy or safety of a medical intervention such as, for example, a drug, surgical procedure or diagnostic test. CODE 2 Supportive care trial Research studies that look at ways to improve the quality of life for patients and survivors. For example, supportive care trials may look at interventions to reduce issues encountered by patients, such as fatigue, nausea, pain, weight loss, higher risk for other diseases, depression and anxiety. These studies often include interventions from other areas of allied health, such as changing nutrition, psychological therapy, physical therapy and a range of group therapies. These may also be known as supportive care studies. CODE 3 Other research study This includes involvement in areas of research that are not covered by either clinical trials or supportive care trials. This may involve providing information and/or tissue for exploratory or lab-based research. |
---|
Source and reference attributes | |
Submitting organisation: | Cancer Australia |
---|
Data element attributes | |
Collection and usage attributes | |
Guide for use: | Record the appropriate code indicating the type of trial or study that the person with cancer has been enrolled in. The type of trial is indicative of the focus of the trial and the potential way that the trial may effect the person. |
---|---|
Collection methods: | Collect from patient medical records. |
Comments: | A measurement of the percentage of patients entering research trials/studies (in particular clinical trials) may have implications for access to, and the provision of, cancer services. |
Source and reference attributes | |
Submitting organisation: | Cancer Australia |
Reference documents: | Stedman TL 2006. Stedman's Medical Dictionary. 28th edition. Maryland: Lippincott Williams & Wilkins |
Relational attributes | |
Related metadata references: | See also Person with cancer—clinical trial experimental agent or intervention, text X[X(399)] Health, Standard 14/05/2015 See also Person with cancer—clinical trial funding basis, code N Health, Standard 04/02/2015 See also Person with cancer—clinical trial identifier, text X[X(399)] Health, Standard 08/05/2014 See also Person with cancer—clinical trial phase, code N Health, Standard 04/02/2015 See also Person with cancer—research enrolment name, text X[X(39)] Health, Standard 04/02/2015 |
Implementation in Data Set Specifications: | Adolescent and young adult cancer (clinical) DSS Health, Superseded 14/05/2015 DSS specific information: This item should be recorded for clinical trials relating to the initial course of treatment and clinical trials relating to the first recurrence of cancer where applicable. Adolescent and young adult cancer (clinical) NBPDS Health, Standard 14/05/2015 DSS specific information: This item should be recorded for clinical trials relating to the initial course of treatment and clinical trials relating to the first recurrence of cancer where applicable. |